We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
–
Cap. Flow
+$3.41B
Cap. Flow %
101.25%
Top 10 Hldgs %
50.48%
Holding
489
New
489
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$483M
2
NVDA icon
NVIDIA
NVDA
+$247M
3
AAPL icon
Apple
AAPL
+$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Miscellaneous 4.78%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
301
Becton Dickinson
BDX
$51.6B
$463K 0.01%
+2,943
New +$540K
EW icon
302
Edwards Lifesciences
EW
$52B
$461K 0.01%
+5,752
New +$474K
FFIV icon
303
F5
FFIV
$22.3B
$457K 0.01%
+1,581
New +$438K
PLD icon
304
Prologis
PLD
$134B
$452K 0.01%
+3,418
New +$457K
LMT icon
305
Lockheed Martin
LMT
$130B
$448K 0.01%
+742
New +$457K
SRPT icon
306
Sarepta Therapeutics
SRPT
$2.2B
$445K 0.01%
+20,453
New +$396K
JCI icon
307
Johnson Controls International
JCI
$84.6B
$443K 0.01%
+3,384
New +$437K
AKAM icon
308
Akamai
AKAM
$15.4B
$442K 0.01%
+3,847
New +$386K
NCLH icon
309
Norwegian Cruise Line
NCLH
$7.65B
$442K 0.01%
+23,616
New +$516K
CB icon
310
Chubb
CB
$131B
$441K 0.01%
+1,354
New +$434K
IMVT icon
311
Immunovant
IMVT
$8.51B
$440K 0.01%
+17,715
New +$459K
AGIO icon
312
Agios Pharmaceuticals
AGIO
$1.99B
$437K 0.01%
+12,915
New +$366K
RARE icon
313
Ultragenyx Pharmaceutical
RARE
$2.52B
$436K 0.01%
+20,796
New +$468K
IRON icon
314
Disc Medicine
IRON
$3.07B
$433K 0.01%
+6,772
New +$470K
IMNM icon
315
Immunome
IMNM
$3.13B
$429K 0.01%
+19,638
New +$437K
PGR icon
316
Progressive
PGR
$127B
$427K 0.01%
+2,154
New +$445K
CDW icon
317
CDW
CDW
$18.5B
$426K 0.01%
+3,523
New +$445K
A icon
318
Agilent Technologies
A
$43.4B
$426K 0.01%
+3,734
New +$474K
COF icon
319
Capital One
COF
$132B
$425K 0.01%
+2,327
New +$487K
BCRX icon
320
BioCryst Pharmaceuticals
BCRX
$2.51B
$424K 0.01%
+44,532
New +$346K
VCYT icon
321
Veracyte
VCYT
$3.48B
$422K 0.01%
+13,100
New +$485K
RMD icon
322
ResMed
RMD
$34.7B
$419K 0.01%
+1,867
New +$465K
WAT icon
323
Waters Corp
WAT
$40.7B
$418K 0.01%
+1,404
New +$480K
PH icon
324
Parker-Hannifin
PH
$125B
$418K 0.01%
+467
New +$442K
DYN icon
325
Dyne Therapeutics
DYN
$4.68B
$417K 0.01%
+23,001
New +$397K
11 12
13
14 15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, E Fund Management held 489 positions worth $3.37B. Its ten largest holdings account for 50% of the portfolio.

E Fund Management deployed $3.41B of net new capital in Q1 2026, opening 489 new positions. Its largest new stake was Pinduoduo: 4,593,053 shares worth $469M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q1 2026 buy was Pinduoduo: 4,593,053 shares worth $469M.
  • E Fund Management's ten largest holdings make up 50% of its $3.37B portfolio in Q1 2026.
  • E Fund Management opened 489 new positions and closed 0 in Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.